2017
DOI: 10.1002/1878-0261.12113
|View full text |Cite
|
Sign up to set email alerts
|

Molecular analysis of single circulating tumour cells following long‐term storage of clinical samples

Abstract: The CellSearch® semiautomated CTC enrichment and staining system has been established as the ‘gold standard’ for CTC enumeration with CellSearch® CTC counts recognized by the FDA as prognostic for a number of cancers. We and others have gone on to show that molecular analysis of CellSearch® CTCs isolated shortly after CellSearch® enrichment provides another valuable layer of information that has potential clinical utility including predicting response to treatment. Although CellSearch® CTCs can be readily isol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 37 publications
0
12
0
Order By: Relevance
“…Whole genome amplification (WGA) was performed using the Ampli1 WGA kit (Menarini) according to the manufacturer's instructions. The efficacy of WGA was then evaluated by a multiplex quality control PCR (Ampli1 QC kit, Menarini) as previously described 26 followed by visualization of PCR bands on a 1.5% (w/v) agarose gel. This quality control step allowed us to establish a Genome Integrity Index (GII) of 0-4 for each sample and single cells with GII≥2 were considered with good quality DNA and eligible for subsequent downstream analysis.…”
Section: Whole Genome Amplificationmentioning
confidence: 99%
“…Whole genome amplification (WGA) was performed using the Ampli1 WGA kit (Menarini) according to the manufacturer's instructions. The efficacy of WGA was then evaluated by a multiplex quality control PCR (Ampli1 QC kit, Menarini) as previously described 26 followed by visualization of PCR bands on a 1.5% (w/v) agarose gel. This quality control step allowed us to establish a Genome Integrity Index (GII) of 0-4 for each sample and single cells with GII≥2 were considered with good quality DNA and eligible for subsequent downstream analysis.…”
Section: Whole Genome Amplificationmentioning
confidence: 99%
“…Reports on the expression of treatment targets on CTC showed extensive intra and inter patient heterogeneity of expression (49)(50)(51). Therefore, it would be great if tools were available to provide a likelihood that the nucleic acids are of sufficient quality after isolation of the single CTC (58,59). For extensive interrogation of the CTC the individual cells will have to be isolated and for molecular characterization the nucleic acids will have to be amplified.…”
mentioning
confidence: 99%
“…As many CTC are undergoing apoptosis, the nucleic acids may not be of a sufficient quality for thorough interrogation. Therefore, it would be great if tools were available to provide a likelihood that the nucleic acids are of sufficient quality after isolation of the single CTC (58,59). This may save effort and cost involved with sequencing, fluorescence in situ hybridization, etc.…”
mentioning
confidence: 99%
“…F o l l o w i n g e n r i c h m e n t a n d i d e n t i f i c a t i o n , t h e molecular characterization of single CTCs requires technology for their isolation, which can be performed by FACS, DEPArray, microfluidic devices or laser capture microdissection. Several overviews and technology articles of the CTC isolation methods used for the genetic analysis have been already published (47)(48)(49)(50)(51)(52).…”
Section: No Universal Technology For Ctc Detection and Evaluationmentioning
confidence: 99%